The University of California San Francisco’s Rosenman Institute has chosen mynurse.ai as a 2020 Rosenman Innovator!
Made up of a community of investors, clinicians and technology entrepreneurs, the UCSF Rosenman Institute’s mission is to help entrepreneurs develop innovative health technologies that will improve patient care.
To that end, the institute selects a cohort of companies as Rosenman Innovators each year based on the patient impact of their technologies. Rosenman Innovators receive coaching in communication, product development, IP, clinical/regulatory strategy and more, as well as valuable in-kind services to support their company’s growth.
mynurse.ai was one of only 13 companies chosen for the prestigious 2020 cohort. Other innovators selected include Nanochon, which is developing a 3D-printed soft implant for treating surface cartilage damage in the knee, and Renata Medical, which is developing an adjustable neonatal stent that grows with patients and eliminates the need for ongoing open-heart surgery.
More than 150 companies applied for this year’s selection, a record number.
“We are thrilled to be able to help such a dynamic group,” says Christine Winoto, founder and director of the UCSF Rosenman Institute. “We have seen many companies in our past cohorts make great progress and reach their milestones, such as obtaining FDA approval. Several have products and services currently in the market.”
Waleed Mohsen, mynurse.ai’s co-founder and CEO, says the institute’s support will help mynurse.ai continue its mission of bridging care gaps and making health care more human.
“UCSF’s Rosenman’s Institute has a record for incubating some of the best health care technology companies in the industry,” says Mohsen. “We’re honored to be a part of this prestigious portfolio and look forward to collaborating with UCSF’s mentors and resources to make sure we’re always putting patients first when it comes to delivering health care tech.”